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S(Heel wound, n¼28), and group E (Extensive wound extending onto the forefoot or
midfoot along with dorsum or plantar surfaces, n¼43). Successful revascularization
was deﬁned as achievement of direct blood ﬂow to the wounds evaluated by digital
subtraction angiography just after EVT.
Results: We achieved successful revascularization 73% in group T, 79% in group H,
and 51% in group E. In success group, wound healing rates were 81% in group T,
59% in group H, and 32% in group E (p < 0.001). On the other hand, in non-success
group, wound healing rates were 53% in group T, 33% in group H, and 0% in group E
(p < 0.001). Time to healing were 50 days (interquartile range: 23-99 days), and 65
days (28-156 days) in group T (p ¼ 0.20): 145 days (121-317 days), and 260 days
(234-285 days) in group H (p ¼ 0.39) with and without successful revascularization.
Conclusions: Successful revascularization increased wound healing rates of all types
wounds, however, time to healing was not statistically different with and without
successful revascularization. Not only successful revascularization but also various
factors are associated with wound healing in patients with CLI.
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Background: Inferior vena cava ﬁlters (IVCF) have increasingly been used for
prevention of pulmonary thromboembolism (PTE) in deep venous thrombosis (DVP)
when anticoagulant therapy is contraindicated or in patients presumed to be at high
risk. Persistent DVP and risk factors or lack of follow-up may account for IVCF left
permanently in place. We assessed long-term performance of permanent IVCF with
abdominal CT scan.
Methods: ALN IVCF (ALN Implants Chirurgicaux) is a retrievable, non-magnetic,
stainless steel ﬁlter consisting of nine legs. Six short legs (SL) provide anchorage and
three long legs (LL) allow coaxial ﬁlter positioning. Among 54 pts with DVP who
received ALN IVCF, 12 pts (58% female, mean age 55 years, range 19-80) with ﬁlter
left permanently in place underwent abdomen CT scan during follow-up. Six pts had
a second CT scan and one pt had four CT scans. Time from IVCF implantation to CT
scan follow-up ranged from 2 to 163 (mean 60) months. Penetration of ﬁlter into the
IVC wall was deﬁned as  3 mm protrusion of a leg outside the IVC wall. Grade 3
penetration was deﬁned as any interaction with an adjacent organ outside the IVC.
Fracture was deﬁned as any loss in structural integrity of the IVCF. Embolization was
deﬁned as remote endovascular migration of a fractured leg.
Results: In all pts (12/12), CT scan showed penetration of ﬁlter legs. Overall, 57/72
(79%) of the SL but only 1/32 (3%) of the LL were outside IVC wall. Grade 3
penetration of 13 (18%) SL was observed in 8(67%) pts: 9 into a vertebral body and 4
into small intestine. In 4 (33%) pts, 11 (15%) SL fractures were observed, while in 3
(25%) pts embolization of a total of 7 SL occurred: 3 in a pulmonary artery branch, 2
in the right side of the heart, 1 in the liver and 1 whose embolization site was not
found. None of the pts had clinical manifestations related to IVCF dysfunction.
Conclusions: IVC injury and loss of IVCF structural integrity seem to be the rule rather
than the exception after prolonged IVCF positioning. These ﬁndings should encourage
IVCF removal when possible. Furthermore, surveillance follow-up with abdominal
X-ray or CT scan in all patients with permanent IVCF is strongly advisable.
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Background: To compare clinical outcomes of endovascular intervention (EVI)
between octogenarians and non-octogenarians with peripheral arterial disease (PAD)
Methods: A retrospective analysis of 490 consecutive patients (619 legs) who
underwent EVI between June 2005 and February 2013, was conducted in a prospec-
tively maintained database. Patients  80 (128 patients, 158 limbs) and < 80 years old
(362 patients, 461 limbs) were compared to demographics, 30-day major adverse
vascular events (MACE), limb salvage, sustained clinical success (SCS), secondary
sustained clinical success (SSCS) and overall survival.
Results: Patients  80 were more likely to be female and have more atrial ﬁbrillation,
whereas those < 80 were more likely to have diabetes mellitus, dialysis dependence,
hyperlipidemia, high body mass index and claudicants. There were more multi-level
interventions in patients 80 (55%vs. 45%,p¼0.04). Theprocedure success rate (93.7%
vs. 94%, p¼1.0) and 30-day MACE were similar in both age groups (10.1% vs. 9.3%,
p¼1.0). The SCS (<80% vs.80, 56% vs. 53%, p¼0.859), SSCS (<80% vs.80, 72%
vs. 76%, p¼0.07) and limb salvage rates (<80% vs.80, 91% vs. 95%, p¼0.085) wereB158 JACC Vol 62/18/Suppl B j October 27–Nsimilar between both age groups at 24 months. Patients80 still have shorter survival as
compared to those <80 (57% vs. 71%, p<0.01) during the follow-up period.
Conclusions: Our results suggest EVI in octogenarian with more complex lesions is
safe and feasible without increasing the risk of complications. Although the overall
survival remained worse in this elderly group, 24-month SCS, SSCS and limb salvage
rate were similar in both age group. For patients 80 with PAD, EVI should be
considered as ﬁrst-line treatment of choice.
TCT-522
The impact of statin therapy for atherosclerotic renal artery stenosis after
percutaneous transluminal renal artery stenting
Hideaki Aihara1, Yoshimitsu Soga2
1Tsukuba medical center hospital, Tsukuba, Japan, 2Kokura Memorial Hospital,
Kitakyushu, Japan
Background: Although percutaneous transluminal renal artery stenting (PTRAS) has
become popular for treating atherosclerotic renal artery stenosis (ARAS), effect of
statin after PTRAS remains uncertain. The aim of this study is to examine the
inﬂuence of statin after PTRAS.
Methods: Consecutive 268 patients who were diagnosed as atherosclerotic renal
artery stenosis by duplex ultrasound and angiography received renal artery stenting,
and they were enrolled in the study between Aug 1996 and July 2010. Data were
collected on clinical outcomes over a mean follow-up period of 4330 months. The
primary endpoint was deﬁned as the composite of all-cause death, hospitalization of
heart failure, and initiation of dialysis.
Results: 89 patients (33%) received statin treatment during follow-up period.
According to Kaplan-Meier analysis, the log-rank test showed patients who received
statin treatment have a lower event rate than patients without statin (Log-rank test;
p¼0.03), and percentage with event was reduced by 10% in the patients with statin
treatment 5years after PTRAS.Conclusions: In conclusion, statin therapy was associated with a better outcome in
patients with atherosclerotic renal artery stenosis who were received PTRAS.
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Background: There are limited data regarding contemporary use and comparative
clinical outcomes of stent and non-stent based revascularization of infra-inguinal
peripheral arterial vessels.ovember 1, 2013 j TCT Abstracts/POSTER/Endovascular Intervention
